PTAC - CAS号查询

热门搜索化学品最多只显示前20条，请点击“搜索化学品”查看所有结果

CAS登录号

中文名

英文名

分子结构式

分子式

详情

供应商

311-89-7

全氟三丁胺;
FC-43

Perfluorotributylamine;
HePTACosafluorotributylamine;
Perfluoro-tri-n-butylamine;
Tris(nonafluorobutyl)amine;
PFTBA

2,3,4,5-四氯-6-(三氯甲基)吡啶;
七氯甲基吡啶

2,3,4,5-Tetrachloro-6-(trichloromethyl)pyridine;
2,3,4,5-Tetrachloro-6-(trichloromethyl)pyridine;
2-(Trichloromethyl)tetrachloropyridine;
3,4,5,6-Tetrachloro-2-(trichloromethyl)pyridine;
HePTAChloro-2-picoline;
Perchloro-2-picoline;
Tetrachloro-2-(trichloromethyl)pyridine

二十七烷

HePTACosane;
n-HePTACosane;
n-HePTACosan

七氯丙烷

1,1,1,2,2,3,3-hePTAChloropropane;
unsym-HePTAChloropropane;
propane,1,1,1,2,2,3,3-hePTAChloro

七氯化茚;
1,4,5,6,7,8,8-七氯-3A,4,7,7A-四氢-4,7-亚甲基-1-茚

1,4,5,6,7,8,8-hePTAChloro-3a,4,7,7a-tetrahydro-7-methanoindene;
hePTAChloor;
hePTAChlor;
hePTAChlor (technical grade);
hePTAChlorane;
rhodiachlor;
soleptax

全氟代十四酸

hePTACosafluoro-tetradecanoic acid;
perfluorotetradecanoic acid

alpha-环糊精-6-单甲苯磺酸酯

a-Cyclodextrin,6A-(4-methylbenzenesulfonate);
a-Cyclodextrin,6-p-toluenesulfonate (8CI);
2,4,7,9,12,14,17,19,22,24,27,29-DodecaoxahePTACyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane,a-cyclodextrin deriv.;
6-O-Tosyl-a-cyclodextrin

2,6-二-甲基-α-环糊精

a-Cyclodextrin, 2A,2B,2C,2D,2E,2F,6A,6B,6C,6D,6E,6F-dodeca-O-methyl-;
2,4,7,9,12,14,17,19,22,24,27,29-DodecaoxahePTACyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane, a-cyclodextrin deriv.;
2,6-Di-O-methyl-a-cyclodextrin;
2,6-Dimethyl-a-cyclodextrin;
Alpha W 6M1.8;
Di-O-methyl-a-cyclodextrin;
Dimethyl-a-cyclodextrin;
Dodecakis-2,6-O-methylcyclohexaamylose;
Hexakis(2,6-O-dimethyl)-a-cyclodextrin;
a-Cyclodextrin dimethyl ether

Hexakis-6-iodo-6-deoxy-α-cyclodextrin

a-Cyclodextrin,6A,6B,6C,6D,6E,6F-hexadeoxy-6A,6B,6C,6D,6E,6F-hexaiodo-;
2,4,7,9,12,14,17,19,22,24,27,29-DodecaoxahePTACyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane,a-cyclodextrin deriv.

苯丙锡-6-(二甲基-叔-丁基甲硅烷基)-α-环糊精

a-Cyclodextrin,6A,6B,6C,6D,6E,6F-hexakis-O-[(1,1-dimethylethyl)dimethylsilyl]-;
2,4,7,9,12,14,17,19,22,24,27,29-DodecaoxahePTACyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane,a-cyclodextrin deriv.;
Hexakis(6-O-tert-butyldimethylsilyl)cyclomaltohexaose;
Hexakis(6-dimethyl-tert-butylsilyl)-a-cyclodextrin

6-O-α-麦芽糖基-α-环糊精

a-Cyclodextrin, O-a-D-glucopyranosyl-(1®4)-O-a-D-glucopyranosyl-(1®6A)-;
2,4,7,9,12,14,17,19,22,24,27,29-DodecaoxahePTACyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane,a-cyclodextrin deriv.;
6-O-(a-Maltosyl)-a-cyclodextrin;
6-O-a-D-Maltosyl-a-cyclodextrin;
Maltosyl-a-cyclodextrin;
a-Maltosyl-a-cyclodextrin

6-O-α-D-葡糖基-α-单环糊精

a-Cyclodextrin, O-a-D-glucopyranosyl-(1®6A)-;
Cyclomaltohexaose,6-O-a-D-glucopyranosyl- (7CI);
2,4,7,9,12,14,17,19,22,24,27,29-DodecaoxahePTACyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane,a-cyclodextrin deriv.;
6-O-(a-Glucopyranosyl)-a-cyclodextrin;
6-O-a-D-Glucopyranosylcyclomaltohexaose;
6-O-a-D-Glucosyl-a-cyclodextrin;
Glucosyl-a-cyclodextrin;
a-Glucosyl-a-cyclodextrin

Aureobasidin I (9CI);
AureobasidinA, 5-L-leucine-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacyclohePTACosine,cyclic peptide deriv.;
Antibiotic R 106VIII;
Cyclo[L-leucyl-N-methyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine, 3-hydroxy-N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-leucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]-

Aureobasidin F (9CI);
AureobasidinA, 6-L-valine-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacyclohePTACosine,cyclic peptide deriv.;
Antibiotic R 106V;
Cyclo[L-alloisoleucyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine, 3-hydroxy-N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]-

a-Cyclodextrin,2A,2B,2C,2D,2E,2F,6A,6B,6C,6D,6E,6F-dodeca-O-pentyl-;
2,4,7,9,12,14,17,19,22,24,27,29-DodecaoxahePTACyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane,a-cyclodextrin deriv.;
Hexakis(2,6-di-O-pentyl)-a-cyclodextrin

a-Cyclodextrin,2A,2B,2C,2D,2E,2F,6A,6B,6C,6D,6E,6F-dodeca-O-pentyl-, hexaacetate (9CI);
2,4,7,9,12,14,17,19,22,24,27,29-DodecaoxahePTACyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane,a-cyclodextrin deriv.;
Hexakis(2,6-di-O-pentyl-3-O-acetyl)-a-cyclodextrin;
Lipodex B

a-Cyclodextrin,6A,6B,6C,6D,6E,6F-hexakis-O-[(1,1-dimethylethyl)dimethylsilyl]-, dodecaacetate(9CI);
2,4,7,9,12,14,17,19,22,24,27,29-DodecaoxahePTACyclo[26.2.2.23,6.28,11.213,16.218,21.223,26]dotetracontane,a-cyclodextrin deriv.;
Hexakis(2,3-di-O-acetyl-6-O-tert-butyldimethylsilyl)cyclomaltohexaose;
Hexakis(6-O-tert-butyldimethylsilyl-2,3-di-O-acetyl)-a-cyclodextrin

Aureobasidin E (9CI);
AureobasidinA, 3-(erythro-b-hydroxy-N-methyl-L-phenylalanine)-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacyclohePTACosine,cyclic peptide deriv.;
Antibiotic R 106-IV;
Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-(bS)-b-hydroxy-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine,3-hydroxy-N-[N-[N-[N-[1-[erythro-b-hydroxy-N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]-;
R 106-4

Aureobasidin G (9CI);
AureobasidinA, 8-(N-methyl-L-valine)-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacyclohePTACosine,cyclic peptide deriv.;
Antibiotic R 106VI;
Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine, N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]-

Aureobasidin K (9CI);
AureobasidinA,1-[N-(2-hydroxy-3-methyl-1-oxobutyl)-N-methyl-L-valine]-8-(N-methyl-L-valine)-,(R)-;
1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]oxaoctaazacyclohePTACosine,cyclic peptide deriv.;
Antibiotic R 106Xa;
Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-N-methyl-L-valyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl];
L-Valine, N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxobutyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, (R)-

C59H90N8O10

详情

供应商

化工产品